Strong Biotech Corporation, founded in June 2000, a renowned Research and Development based company in Taiwan, holds key technologies in the fields of immunology, microbial fermentation, molecular biology, recombinant DNA, and Proteomics. Through years of efforts in developing manufacturing protocol and quality control SOP, Strong Biotech Corporation has evolved from a research and development based company into a product and service oriented corporation, with superior quality control and cost control. Strong Biotech Corporation is now a biotech company with world class R&D and product teams that ensure the best quality of all of our products. In terms of corporate development philosophy, we have a global perspective with specific programs to develop specialized medical and biotech products which meet the demand of the global market. Strong Biotech Corporation has become the world technology leader in H. pylori rapid urease test with the most complete solution for testing H. pylori through endoscope. Strong Biotech Corporation will always strive to achieve our goal of “Our Care is Worldwide” in continually developing people caring products in medical and R&D fields.

• ODM of Diagnostic and Research products.
• Supply of raw material in Medical Cosmetics filed.
• Specific gene cloning and sequencing.
• Special protein expression and quantitative production/purification.
• Microbial fermentation and product analysis.
• Selection system of new anti-tumor drugs.

    In the first stage, Strong Biotech Corp. focused on delivering products with the best quality-price ratio to build up a positive company image, to win the users’ confidence, and to increase our market share. In the second stage, our exclusive technology platform allows us to develop a series of diagnostic kits, research kits and raw material for cosmetics with higher commercial value, while meeting demand of market and keeping on pace with the international biotechnology trend. After we obtained the CE certification on October, 2008, our aim is to keep on building a global distribution network to share our innovations with everyone, everywhere, in the hope of maintaining our leading position in the biomedical field worldwide.